HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences' (HSCS) quarterly Gross Margin came in at 58.33% in Q4 2025, down 2.78% on a QoQ basis from 60.0% in Q3 2025.

HeartSciences (HSCS) Gross Margin (2021 - 2025) Analysis & Trends

HeartSciences (HSCS) has 5 years of Gross Margin data on file, last reported at 58.33% in Q4 2025.

Quarterly Gross Margin changed N/A year-over-year to 58.33% in Q4 2025, while the trailing twelve-month figure through Apr 2026 was 57.92% (down 827.0% YoY) and the FY2026 annual result came in at 59.06%, up 228.0% from the prior year.
Gross Margin retreated to 58.33% in Q4 2025, from 60.0% in the prior quarter.
In the past five years, Gross Margin ranged from a high of 69.15% in Q2 2022 to a low of 23.09% in Q3 2021.
A 5-year average of 56.36% and a median of 60.51% in 2025 frame the typical range for Gross Margin.
Annual changes were most pronounced in 2022 — Gross Margin soared 1329 bps — and 2023, when it tumbled 781 bps.
Tracing HSCS's Gross Margin over 5 years: stood at 23.09% in 2021, then jumped by 58 bps to 36.38% in 2022, then soared by 68 bps to 61.03% in 2023, then advanced by 13 bps to 68.97% in 2024, then slipped by 15 bps to 58.33% in 2025.
The last three Gross Margin figures came in at 58.33% (Q4 2025), 60.0% (Q3 2025), and 56.78% (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn	57.71%
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn	68.27%
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn	65.35%
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn	77.46%
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn	47.38%
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn	45.84%
10	HeartSciences	6.64 Mn	4.94 Mn	-	-

Download Data